1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
BioTools Innovator VANGUARD is a grant from BARDA (Biomedical Advanced Research and Development Authority) that funds the development of innovative medical diagnostics, devices, and platform technologies that can be rapidly deployed during public health emergencies.
The program supports companies at the early validation and prototype stage working on diagnostic tools, point-of-care devices, or platform technologies with dual-use applications in both emergency and routine care settings. Eligible applicants are U.S.-based companies with a demonstrated prototype and development timeline. Awards range from $50,000 to $200,000 for a 6-month milestone-based engagement.
Get alerted about grants like this
Save a search for “Biomedical Advanced Research and Development Authority (BARDA/HHS)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Leading accelerator program for life science enabling technologies. Enabling Technologies Hub BARDA Accelerator Network Enabling the Development of Innovations in Drug Discovery and Development, Biomanufacturing, and Bioanalytic and Diagnostic Instrumentation to Improve Clinical Research and Response BioTools Innovator VANGUARD is at the forefront of innovation for enabling life science technologies.
VANGUARD supports biotools startups to develop solutions that improve drug discovery and development; to increase biomanufacturing speed, capacity, portability, and scalability; to enhance sample processing efficiency and diagnostic assay capabilities; and to accelerate bioanalysis of emerging pathogens.
VANGUARD stands ready to support startups in deploying innovative medical countermeasures that enhance the United States’ readiness for public health emergencies.
VANGUARD is a joint initiative between BioTools Innovator, the world’s first-ever accelerator focused on life science research tools, and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services.
BioTools Innovator VANGUARD Opportunities BioTools Innovator VANGUARD consists of two programs, a health security-focused accelerator track as part of the core BioTools Innovator annual cohort, and a specialized technical development, evaluation, and validation non-dilutive funding opportunity. Companies may apply to either or both programs.
BioTools Accelerator Program Track The BioTools Innovator VANGUARD Accelerator will select up to 10 companies annually to participate in a specialized track of the BioTools Innovator accelerator, a four-month program.
Non-Dilutive Funding Program BioTools VANGUARD provides non-dilutive funding to support the Development, Evaluation, and Validation program for technologies that advance BARDA’s mission to enhance pandemic preparedness and health security.
Through Level UP-XR: Training for Biopharmaceutical Manufacturing Technicians, BioTools Innovator VANGUARD will provide non-dilutive funding to innovative CDMO and XR companies creating next-generation training solutions that strengthen the biopharmaceutical manufacturing workforce. Congratulations to our 2025 VANGUARD Cohort!
The BARDA Accelerator Network In Partnership with the Biomedical Advanced Research and Development Authority The BARDA Accelerator Network aims to provide comprehensive support to health security innovators, startups and BARDA portfolio companies through wrap-around accelerator services, technical and business/commercialization expertise, and resources.
The network will facilitate the rapid development, evaluation, validation and commercialization of medical countermeasures. Learn more at the BARDA Accelerator Network . BARDA Accelerator Network Hubs The BARDA Accelerator Network, made up of five Hubs, is built to drive growth in the startup ecosystem by speeding up the creation and market entry of cutting-edge health security solutions.
Each Hub sources promising early-stage innovations within their specialized technology areas and offers funding to evaluate the feasibility of these concepts and provides resources for commercialization, helping to fast-track product development and validation.
BioTools Innovator VANGUARD is at the forefront of biomanufacturing innovation, enabling life science tools startups to develop solutions that improve drug discovery and development; increase speed, capacity, portability, and scalability; and improve clinical research and clinical care coordination.
Diagnostics & Medical Devices The International Consortium for Research, Engineering, Acceleration of Technology Excellence (I-CREATE) Hub supports the development and acceleration of novel diagnostics and medical devices to detect, prevent, or respond to medical consequences that result from health security threats.
Focus on innovations that can improve the detection, diagnosis, treatment, and informed outcomes in pediatric/neonatal populations and immunocompromised populations to enable health equity solutions in traditionally underrepresented communities and low-resource settings.
Therapeutics and Vaccines The Vaccine Innovations and Therapeutics Acceleration Launchpad (VITAL) Hub will support the development and acceleration of next-generation therapeutic and vaccine platforms and technologies. Focus on the development and application of digital health tools to empower people to prepare for and respond to health security threats and improve the continuum of clinical care.
BioTools Innovator VANGUARD is at the forefront of biomanufacturing innovation, enabling life science tools startups to develop solutions that improve drug discovery and development; increase speed, capacity, portability, and scalability; and improve clinical research and clinical care coordination.
Diagnostics & Medical Devices The International Consortium for Research, Engineering, Acceleration of Technology Excellence (I-CREATE) Hub supports the development and acceleration of novel diagnostics and medical devices to detect, prevent, or respond to medical consequences that result from health security threats.
Focus on the development and application of digital health tools to empower people to prepare for and respond to health security threats and improve the continuum of clinical care.
Focus on innovations that can improve the detection, diagnosis, treatment, and informed outcomes in pediatric/neonatal populations and immunocompromised populations to enable health equity solutions in traditionally underrepresented communities and low-resource settings.
Therapeutics and Vaccines The Vaccine Innovations and Therapeutics Acceleration Launchpad (VITAL) Hub will support the development and acceleration of next-generation therapeutic and vaccine platforms and technologies. For additional information and questions, please contact vanguard@biotoolsinnovator. org .
Based on current listing details, eligibility includes: Startups and university-backed projects developing novel biotools and enabling technologies for health security applications Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $50,000-$200,000 for 6-month milestone-based projects Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Research Project Grant (R01) is sponsored by National Institutes of Health (NIH). The NIH R01 grant is a widely used mechanism to provide substantial support for health-related research projects. While not exclusively for social work, social work faculty and doctoral students (often as part of a research team) can apply for R01 funding for projects exploring the linkages between education and health, or social work practice and health outcomes.
Small Research Grant Program (R03) is sponsored by National Institutes of Health (NIH). The NIH R03 grant supports small, time-limited research projects, which can include dissertation research. This grant mechanism is suitable for social work scholars conducting pilot studies, developing new methodologies, or performing secondary data analysis relevant to NIH's public health goals.